-
公开(公告)号：US08816073B2
公开(公告)日：2014-08-26
申请号：US13936382
申请日：2013-07-08
发明人： Viswajanani J. Sattigeri , Venkata P. Palle , Manoj Kumar Khera , Ranadheer Reddy , Manoj Kumar Tiwari , Ajay Soni , Abdul Rehman Abdul Rauf , Sony Joseph , Arpita Musib , Sunanda G. Dastidar , Punit Kumar Sricastava
IPC分类号： C07D401/06 , C07D401/14 , A61K31/53 , A61P19/02
CPC分类号： A61K31/4155 , A61K31/4035 , A61K31/41 , A61K31/438 , A61K31/4439 , A61K31/444 , A61K31/502 , A61K31/506 , A61K31/517 , A61K31/53 , A61K31/536 , A61K45/06 , C07D209/44 , C07D209/48 , C07D253/08 , C07D265/26 , C07D401/06 , C07D401/10 , C07D401/14 , C07D403/10 , C07D405/10 , C07D409/06 , C07D409/10 , C07D409/14 , C07D413/10
摘要： The present invention relates to β-hydroxy and amino-substituted carboxylic acids, which act as matrix metalloproteinase inhibitors, particularly diastereomerically pure β-hydroxy carboxylic acids, corresponding processes for their synthesis, and pharmaceutical compositions containing the compounds of the present invention. Compounds of the present invention are useful in the treatment of various inflammatory, autoimmune, and allergic diseases, such as methods of treating asthma, rheumatoid arthritis, COPD, rhinitis, osteoarthritis, psoriatic arthritis, psoriasis, pulmonary fibrosis, wound healing disorders, pulmonary inflammation, acute respiratory distress syndrome, perodontitis, multiple sclerosis, gingivitis, atherosclerosis, neointimal proliferation, which leads to restenosis and ischemic heart failure, stroke, renal diseases, tumor metastasis, and other inflammatory disorders characterized by the over-expression and over-activation of a matrix metalloproteinase.
摘要翻译： 本发明涉及作为基质金属蛋白酶抑制剂，特别是非对映异构体纯的羟基羧酸，其合成方法及其含有本发明化合物的药物组合物的β-羟基和氨基取代的羧酸。 本发明的化合物可用于治疗各种炎性，自身免疫性和过敏性疾病，例如治疗哮喘，类风湿性关节炎，COPD，鼻炎，骨关节炎，银屑病关节炎，牛皮癣，肺纤维化，伤口愈合障碍，肺部炎症 ，急性呼吸窘迫综合征，牙周炎，多发性硬化，牙龈炎，动脉粥样硬化，新内膜增生，其导致再狭窄和缺血性心力衰竭，中风，肾脏疾病，肿瘤转移和其他以过表达和过度激活为特征的炎症性疾病 基质金属蛋白酶。
-
公开(公告)号：US08846910B2
公开(公告)日：2014-09-30
申请号：US13936439
申请日：2013-07-08
发明人： Viswajanani J. Sattigeri , Venkata P. Palle , Manoj Kumar Khera , Ranadheer Reddy , Manoj Kumar Tiwari , Ajay Soni , Abdul Rehman Abdul Rauf , Sony Joseph , Arpita Musib , Sunanda G. Dastidar , Punit Kumar Srivastava
IPC分类号： C07D253/08 , A61K31/53 , A61P19/02 , A61K31/502 , A61K31/41 , A61K31/517 , C07D401/14 , C07D401/10 , C07D401/06 , C07D209/48 , C07D409/06 , A61K31/4155 , C07D209/44 , C07D405/10 , A61K31/438 , C07D413/10 , A61K31/444 , A61K31/536 , A61K31/506 , C07D403/10 , C07D409/10 , A61K31/4439 , A61K31/4035 , A61K45/06 , C07D409/14 , C07D265/26
CPC分类号： A61K31/4155 , A61K31/4035 , A61K31/41 , A61K31/438 , A61K31/4439 , A61K31/444 , A61K31/502 , A61K31/506 , A61K31/517 , A61K31/53 , A61K31/536 , A61K45/06 , C07D209/44 , C07D209/48 , C07D253/08 , C07D265/26 , C07D401/06 , C07D401/10 , C07D401/14 , C07D403/10 , C07D405/10 , C07D409/06 , C07D409/10 , C07D409/14 , C07D413/10
摘要： The present invention relates to β-hydroxy and amino-substituted carboxylic acids, which act as matrix metalloproteinase inhibitors, particularly diastereomerically pure β-hydroxy carboxylic acids, corresponding processes for their synthesis, and pharmaceutical compositions containing the compounds of the present invention. Compounds of the present invention are useful in the treatment of various inflammatory, autoimmune, and allergic diseases, such as methods of treating asthma, rheumatoid arthritis, COPD, rhinitis, osteoarthritis, psoriatic arthritis, psoriasis, pulmonary fibrosis, wound healing disorders, pulmonary inflammation, acute respiratory distress syndrome, perodontitis, multiple sclerosis, gingivitis, atherosclerosis, neointimal proliferation, which leads to restenosis and ischemic heart failure, stroke, renal diseases, tumor metastasis, and other inflammatory disorders characterized by the over-expression and over-activation of a matrix metalloproteinase.
-
搜索结果
2 条记录 (耗时 0.013 秒)
